Cargando…
CAR-Based Immunotherapy of Solid Tumours—A Survey of the Emerging Targets
SIMPLE SUMMARY: A rapidly emerging new approach to treat cancer involves collection of patient immune white blood cells and genetic re-programming of the cells to express a new cancer-detecting receptor called a CAR. This approach has revolutionized the treatment of some blood cancers, whereas solid...
Autores principales: | Maher, John, Davies, David M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953954/ https://www.ncbi.nlm.nih.gov/pubmed/36831514 http://dx.doi.org/10.3390/cancers15041171 |
Ejemplares similares
-
CAR Based Immunotherapy of Solid Tumours—A Clinically Based Review of Target Antigens
por: Maher, John, et al.
Publicado: (2023) -
Recent Advances in CAR-Based Solid Tumor Immunotherapy
por: Shin, Min Hwa, et al.
Publicado: (2023) -
Prospects for Development of Induced Pluripotent Stem Cell-Derived CAR-Targeted Immunotherapies
por: Mazza, Roberta, et al.
Publicado: (2021) -
Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T
por: Liu, Qiaofei, et al.
Publicado: (2023) -
S79. CAR strategies in solid tumours
por: Rossig, C
Publicado: (2014)